Citizen Petitions Cannot Be Used To Block Generics - FDA Proposed Rule
Executive Summary
Innovator pharmaceutical companies will not be able to block approval of generic drugs by using the citizen petition mechanism, according to FDA's Nov. 30 proposed rule to revise the petition process.
You may also be interested in...
Citizen Petition Proposed Rule Withdrawn; FDA Cites Improved Response Rate
FDA is withdrawing its proposed rule to limit citizen petitions due to improvements in its response rate
Citizen Petition Proposed Rule Withdrawn; FDA Cites Improved Response Rate
FDA is withdrawing its proposed rule to limit citizen petitions due to improvements in its response rate
FDA Citizen Petition Rule On Hold; Pregnancy Label Work Continues
FDA is no longer pursuing a final rule on limiting the use of citizen petitions